Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Home
/
Records
/
Fda Inspections
/
AstraZeneca Pharmaceuticals LP

FDA Inspection

•AstraZeneca Pharmaceuticals LP•January 14, 2026

FDA Inspection 1299436 - AstraZeneca Pharmaceuticals LP - January 14, 2026

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns AstraZeneca Pharmaceuticals LP, with an inspection on January 14, 2026, covering drugs.

Company: AstraZeneca Pharmaceuticals LP
Inspection Date: January 14, 2026
Product Type: Drugs

Open in Dashboard

ID · 2c679062-e213-4b23-a225-08c290a553f8

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA Inspection 1299436 - AstraZeneca Pharmaceuticals LP - January 14, 2026 | Global Key Solutions